Genmab | GEN - Capitalización De Mercado

Precio De Mercado
1,756.00
Cambio Diario
-19.00 -1.07%
Mensual
-9.09%
Anual
5.82%
Q1 Expectativa
1,751.45




Capitalización De Mercado Cambio Fecha
Agios Pharmaceuticals USD 1.59B 745M 2025-12
Almirall EUR 2.66B 102.29M 2026-03
Amarin USD 341M 4M 2025-09
Amgen USD 176.25B 24.32B 2025-12
argenx SE USD 38.95B 12.88B 2026-03
AstraZeneca USD 288.15B 55.08B 2025-12
Bayer EUR 36.89B 535.42M 2026-03
BioMarin Pharmaceutical USD 11.76B 348M 2026-03
Demant DKK 46.01B 10.48B 2025-12
Exelixis USD 11.75B 959M 2025-12
Fresenius Medical Care EUR 11.68B 275.81M 2026-03
Galapagos EUR 1.89B 49.73M 2026-03
Genmab DKK 80.88B 7.82B 2025-06
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
GN Store Nord DKK 16.11B 98.09M 2025-12
GRIFOLS EUR 4.43B 3.06B 2026-03
Hikma Pharmaceutical USD 2.92B 1.72B 2026-03
Insmed USD 37.12B 6.68B 2025-12
Lonza CHF 39.68B 980.61M 2025-06
Merck EUR 49.2B 1.61B 2026-03
Novartis USD 265.66B 9.48B 2025-09
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 100.88B 4.46B 2025-12
UCB EUR 32.47B 4.91B 2025-06